CollPlant Biotechnologies... (CLGN)
NASDAQ: CLGN
· Real-Time Price · USD
2.50
-0.11 (-4.21%)
At close: Aug 15, 2025, 3:57 PM
2.56
2.40%
After-hours: Aug 15, 2025, 06:26 PM EDT
CollPlant Biotechnologies Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -1.45M | -3.88M | -4.33M | -4.21M | -4.2M | -4.69M | -4.38M | 5.76M | -3.71M | -4.4M | -4.38M | -4.29M | -3.86M | -3.77M | -3.08M | -3.04M | 10.12M |
Depreciation & Amortization | 244K | 242K | 255K | 261K | 280K | 284K | 272K | 266K | 280K | 294K | 281K | 261K | 240K | 224K | 197K | 179K | 173K |
Stock-Based Compensation | 382K | 424K | 515K | 490K | 290K | 564K | 521K | 338K | 514K | 439K | 680K | 594K | 461K | 275K | 368K | 469K | 485K |
Other Working Capital | -156K | 93.3K | -11K | -446.25K | 12K | 482.94K | 62K | -514K | 96K | 478.33K | -188.1K | -632K | -298K | 886K | -391K | -956K | -300K |
Other Non-Cash Items | 3K | -69.3K | -46K | 122K | 740K | -82.37K | -21K | 173K | 282K | -91K | -28K | 448K | 192K | 67K | 91K | -31K | -155K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 23.61K | 134K | n/a | n/a | n/a | n/a | n/a | n/a | -206K | -101K | 81K | -68K |
Change in Working Capital | -344K | -182.7K | 154K | -591K | 247K | 1.64M | 10.25M | -10.28M | -811K | 413K | 261K | -973K | -245K | 992K | -295K | -920K | 439K |
Operating Cash Flow | -1.17M | -3.46M | -3.45M | -3.93M | -3.25M | -2.26M | 6.78M | -3.74M | -3.45M | -3.35M | -3.19M | -3.96M | -3.21M | -2.42M | -2.82M | -3.26M | 11M |
Capital Expenditures | -9K | -59K | -140K | -202K | -82K | -218.38K | -243K | -337K | -145K | -304K | -322K | -388K | -302K | -507K | -635K | -268K | -179K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | 65.61K | n/a | n/a | n/a | n/a | 249.5K | -45K | n/a | 33.79K | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -203.38K | 911.91 | -58.05K | n/a | 20M | 156.42K | -20M | n/a | -10M | 10M | -30.05M | -30M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 143K | n/a | n/a | n/a | -50.24M | -392.92K | 20.05M | 30.19M | n/a | 10M | n/a | n/a |
Other Investing Acitivies | 1K | 1K | n/a | -57K | n/a | -143K | -911.91 | -949 | n/a | 30.24M | -13K | 45K | 30.18M | 33K | 9.97M | -30M | -56K |
Investing Cash Flow | -8K | -58K | -140K | -259K | -82K | -356.15K | -243K | -396K | -145K | -304K | -322K | -337K | 29.89M | -10.47M | 9.37M | -30.27M | -179K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | 9K | n/a | 216K | 89K | 803K | 400K | n/a | n/a | 1.47M | 142K | 1.75M | 1.36M | 2.77M |
Financial Cash Flow | n/a | n/a | n/a | n/a | 9K | -3.95K | 216K | 89K | 803K | 400K | -11.53K | -33.25K | 1.47M | 142K | 1.75M | 1.36M | 35.51M |
Net Cash Flow | -1.17M | -3.46M | -3.55M | -4.3M | -3.45M | -2.29M | 6.62M | -4.42M | -3.07M | -3.16M | -3.48M | -4.79M | 27.92M | -12.6M | 8.3M | -32.25M | 46.4M |
Free Cash Flow | -1.18M | -3.52M | -3.59M | -4.13M | -3.33M | -2.48M | 6.53M | -4.08M | -3.6M | -3.65M | -3.51M | -4.34M | -3.51M | -2.93M | -3.45M | -3.53M | 10.82M |